Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.

We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.

The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.
Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.
We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.
The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.

Thrombosis-preventing Elastic Stocking
Life Science Business is developing biomaterials improving the effect of elastic stockings by local transdermal application of natural thrombosis-preventing compounds. This novel approach is specifically aimed for use by consumers at elevated risk for temporarily deep vein thrombosis, such as long-distance travellers who have other risk factors for thrombosis (Factor VLeiden, use of oral contraceptives, etc.).

The Thrombosis Elastic stocking is developed by Life Science Business to improve the prevention of local thrombosis. Several vitamins are involved (in)directly in vascular health and elastic blood vessels. Besides the known risk factors for developing arteriosclerosis (hypertension, diabetes, overweight, smoking, etc) a low intake of these vitamins also increases stiffening of the blood vessels and thus the risk of thrombosis (for example, a thrombosis leg on long flights).

Office Europe:
Life Science Business
Flight Forum 40
5657 DB Eindhoven
The Netherlands

Contact information:
E: info@lifesciencebusiness.nl

Tel.: 0031-(0)40 - 7983021

Office The Middle East :
Life Science Business
P. O. Box: 122022
Sharjah
The UAE